Company intelligence / Profile preview

Progenerative Medical

San Antonio, Texas, United Statesprogenerative.com ↗

Ownership: Private
Development stage: Other

Overview

Progenerative Medical is developing the Regenn Therapy System, a reduced pressure therapy medical device designed to improve bone healing and integration in orthopedic surgeries, particularly spinal fusion. The technology has demonstrated efficacy in preclinical studies and is being advanced toward first-in-human clinical trials with plans for multi-center studies to expand performance claims. The company holds an exclusive worldwide license to a significant intellectual property portfolio supporting its approach.

Therapeutic areas: Other
Modalities: DeviceReduced pressure therapy system
Industry: Therapeutic Medical Devices

Beyond the preview

Go deeper on Progenerative Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Progenerative Medical.

Explore the full profile